261 related articles for article (PubMed ID: 19211447)
1. Re: Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
Eisinger F; Huiart L
J Natl Cancer Inst; 2009 Feb; 101(4):277; author reply 277-8. PubMed ID: 19211447
[No Abstract] [Full Text] [Related]
2. Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.
Chlebowski RT; Prentice RL
J Natl Cancer Inst; 2008 Oct; 100(19):1341-3. PubMed ID: 18812547
[No Abstract] [Full Text] [Related]
3. Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1-2 mutation carriers.
Biglia N; Mariani L; Ponzone R; Sismondi P
Maturitas; 2008 Jun; 60(2):71-7. PubMed ID: 18472232
[No Abstract] [Full Text] [Related]
4. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of BRCA1 and BRCA2 carriers: bitter choices slightly sweetened.
Rubinstein WS
J Clin Oncol; 2005 Nov; 23(31):7772-4. PubMed ID: 16219930
[No Abstract] [Full Text] [Related]
6. Transmission of mutant alleles to female offspring of BRCA1 carriers in Poland.
Gronwald J; Byrski T; Huzarski T; Narod SA; Lubinski J
J Med Genet; 2005 Jul; 42(7):e40. PubMed ID: 15994865
[No Abstract] [Full Text] [Related]
7. Decision factors influencing hormone replacement therapy.
Rozenberg S; Kroll M; Vandromme J
Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():92-7; discussion 97-8. PubMed ID: 8624351
[No Abstract] [Full Text] [Related]
8. [Present status concerning hormone replacement therapy in menopause and the risk of breast cancer].
Lopes P
J Gynecol Obstet Biol Reprod (Paris); 1998 Oct; 27(1 Suppl):12-6. PubMed ID: 9864684
[No Abstract] [Full Text] [Related]
9. [Alarming data on the risk of breast cancer following estrogen replacement therapy should be interpreted carefully].
Odlind V
Lakartidningen; 2005 Apr 18-24; 102(16):1217-8. PubMed ID: 15921094
[No Abstract] [Full Text] [Related]
10. Quality of life in asymptomatic BRCA1/2 mutation carriers.
Dagan E; Shochat T
Prev Med; 2009 Feb; 48(2):193-6. PubMed ID: 19084553
[TBL] [Abstract][Full Text] [Related]
11. Genetic predisposition testing for breast cancer.
Schulman JD; Stern HJ
Cancer J Sci Am; 1996; 2(5):244-9. PubMed ID: 9166539
[No Abstract] [Full Text] [Related]
12. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.
Khoury-Shakour S; Lejbkowicz F; Barnett-Griness O; Tamir A; Pinchev M; Rennert G
Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use and BRCA penetrance: a case-only study.
Pasanisi P; Hédelin G; Berrino J; Chang-Claude J; Hermann S; Steel M; Haites N; Hart J; Peled R; Gafà L; Leggio L; Traina A; Amodio R; Primic-Zakelj M; Zadnik V; Veidebaum T; Tekkel M; Berrino F
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2107-13. PubMed ID: 19549808
[TBL] [Abstract][Full Text] [Related]
14. [Does menopausal hormonal replacement therapy increase the risk of breast cancer?].
Punnonen R
Duodecim; 1996; 112(12):1110-5. PubMed ID: 10593013
[No Abstract] [Full Text] [Related]
15. [Hormone replacement therapy and breast cancer--any news?].
Holli K
Duodecim; 1999; 115(2):101-2. PubMed ID: 11830839
[No Abstract] [Full Text] [Related]
16. Prophylactic surgery in the complex decision-making management of BRCA mutation carriers.
Briasoulis E; Ziogas D; Fatouros M
Ann Surg Oncol; 2008 Jun; 15(6):1788-90; author reply 1791-2. PubMed ID: 18197455
[No Abstract] [Full Text] [Related]
17. Breast cancer prevention in BRCA1/2 mutation carriers: a qualitative review.
Fuller S; Liebens F; Carly B; Pastijn A; Rozenberg S
Breast J; 2008; 14(6):603-4. PubMed ID: 19054005
[No Abstract] [Full Text] [Related]
18. Nutrition and breast cancer among sporadic cases and gene mutation carriers: an overview.
Bissonauth V; Shatenstein B; Ghadirian P
Cancer Detect Prev; 2008; 32(1):52-64. PubMed ID: 18400416
[TBL] [Abstract][Full Text] [Related]
19. Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers.
Matloff ET; Barnett RE; Bober SL
Cancer J; 2009; 15(1):15-8. PubMed ID: 19197168
[TBL] [Abstract][Full Text] [Related]
20. Serum proteomics for BRCA1-associated breast cancer.
Meric-Bernstam F
Ann Surg Oncol; 2004 Oct; 11(10):883-4. PubMed ID: 15383421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
